TEKMIRA PHARMACEUTICALS CORP - COM NEW (TKMR)

CUSIP: 87911B209

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM NEW
Total 13F shares
4,955,655
Share change
-49,470
Total reported value
$39,488,940
Price per share
$7.97
Number of holders
24
Value change
-$393,662
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 87911B209?
CUSIP 87911B209 identifies TKMR - TEKMIRA PHARMACEUTICALS CORP - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TEKMIRA PHARMACEUTICALS CORP - COM NEW (TKMR) as of Q4 2013

As of 31 Dec 2013, TEKMIRA PHARMACEUTICALS CORP - COM NEW (TKMR) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,955,655 shares. The largest 10 holders included FRANKLIN RESOURCES INC, BANK OF MONTREAL /CAN/, SABBY MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, PointState Capital LP, MARXE AUSTIN W & GREENHOUSE DAVID M, BAILARD, INC., BOGLE INVESTMENT MANAGEMENT L P /DE/, ACADIAN ASSET MANAGEMENT LLC, and I.G. INVESTMENT MANAGEMENT, LTD.. This page lists 24 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.